Funding Opportunities

European & International Funding

number of European and International funds are available to UK based healthcare companies and researchers.

European Research Council: Starting Grants
Researchers of any nationality with 2-7 years of experience since completion of PhD (Extensions are possible under certain circumstances — see the latest ERC Work Programme), a scientific track record showing great promise and an excellent research proposal.
Starting Grants may be awarded up to €1.5 million for a period of 5 years. (pro rata for projects of shorter duration). However, an additional €1 million can be made available to cover eligible “start-up” costs for researchers moving from a third country to the EU or an associated country and/or the purchase of major equipment and/or access to large facilities and/or other major experimental and field work costs.
Deadline: 16 October 2019
Click here for more information

European Research Council: Proof of Concept Grants
The ERC Proof of Concept funding is made available only to those who already have an ERC award to establish proof of concept of an idea that was generated in the course of their ERC-funded projects.
The activities to be funded shall draw substantially on this scientifically excellent ERC-funded research. However, the additional funding is not aimed at extending the original research or predominantly concerned with overcoming obstacles to practical application.
The funding will cover activities at the very early stage of turning research outputs into a commercial or socially valuable proposition, i.e. the initial steps of pre-competitive development.
The funding can be used to:
• Establish viability, technical issues and overall direction
• Clarify intellectual property rights position and strategy
• Provide feedback for budgeting and other forms of commercial discussion
• Provide connections to later stage funding
• Cover initial expenses for establishing a company
Deadline: The new call should open on 15 October 2019
Click here for more information

Horizon 2020: KTN opportunities and information
The UK government has issued some documents to clarify the UK’s eligibility to participate in Horizon 2020 if there is no Brexit deal. Currently open calls include:
Fast Track to Innovation – aims to accelerate the market uptake of ground-breaking innovations by providing funding through an open, accessible scheme that nurtures ideas from consortia of innovators of all types and sizes from across Europe.
Deadline: Various deadlines throughout 2019 and 2020. Next one is 22 October 2019
Click here for more information

Horizon 2020: Anti-Superbugs PCP (Grant Agreement 688878)
Six leading European procuring entities, under the lead of AQuAS, challenge industry to develop smart ICT solutions able to detect the presence of resistant microorganisms, give real-time feedback to the user and at the same time share the information with the healthcare provider electronic record systems, linking the infection with the place of the detection.
The Available budget for the research, development and testing of these innovative solutions is 3.45 million Euro (VAT included).
The call documents will be published on the TED platform. The link is available on the project website here, and the public procurement platform here. The full administrative and technical details for the tender can be found here.

The procurement will take the form of a pre-commercial procurement (PCP) under which R&D service contracts will be awarded to a number of R&D providers in parallel in a phased approach. This will make it possible to compare competing alternative solutions.
Each selected operator will be awarded a framework agreement that covers 3 R&D phases:
• Phase 1: Up to solution design
• Phase 2: Up to a validated prototype
• Phase 3: Up to original development, validation and testing of a limited set of first products or services.
The procurement – from the tender procedure until the subsequent performance of contracts – is expected to start in 28/07/2019 and to end in 29/08/2021.
The selected operators will retain ownership of the intellectual property rights (IPRs) that they generate during the PCP and will be able to use them to exploit the full market potential of the developed solutions beyond the Buyer Group.
This is a joint procurement involving different countries, and the state applicable national procurement law is the Spanish one.

The lead procurer (Agència de Qualitat i Avaluació Sanitària de Catalunya) is appointed to coordinate and lead the joint PCP, and to sign and award the framework agreement and the specific contracts for all phases of the PCP, in the name and on behalf of the following Buyers Group:
ICO/ VINCat (Catalan Institute of Oncology/Catalan Nosocomial Infections Surveillance Programme), Spain
UKA (Aachen University Hospital), Germany
STH (Sheffield Teaching Hospitals NHS Foundation Trust), UK on behalf of NIHR Devices for Dignity MedTech Co-operative
PAT (Provincia Autonoma di Trento), Italy
HELIOS (HELIOS Universitätsklinikum Wuppertal), Germany
FMT (Fundació Mutua de Terrassa), Spain.
The Lead Procurer is not part of the Buyers Group and the EU is not participating as a contracting authority in this procurement.
The consortium comprises also the following partners, who provide a scientific-technical and/or legal support :
Sara Bedin, Independent expert on Innovation Public Procurement and PCP specialist
Deadline: 28 October 2019
For further information click here

H2020: Industrial Leadership – Dedicated SME Instrument 2019
The SME Instrument provides full-cycle business innovation support. It has three phases, includes a coaching and mentoring service, and applications will be accepted throughout 2019 for Phase 1 and Phase 2:
•Phase 1: Feasibility study. Funding is a lump sum of €50,000 Projects should last around six months
•Phase 2: From concept to market. Grant funding is provided (funding rate 70%) of between €500,000 and €2.5 million. Projects should normally take 12 to 24 months to complete but could be longer in exceptional and well-justified cases.
•Phase 3: Commercialisation. Additional EU support extended via a range of business support services offered on the EIC Community Platform, open to SMEs benefiting from the different EIC calls for proposals.
Deadlines in 2019 for Phase 1 proposals are: 6 November 2019.
Deadlines in 2019 for Phase 2 proposals are: 9 October 2019.

Click here for more information.

European & Developing Countries Clinical Trials Partnership

New Drugs and Vaccines for Priority Pathogens in Antimicrobial Resistance 2019
The purpose of this call is to provide funding for clinical trials to be conducted in sub-Saharan Africa which aim to develop new or improved medicinal products (drugs and vaccines) or combinations thereof against pathogens from the WHO priority list that also fall within the scope of the EDCTP2 programme, specifically Campylobacter, Salmonella, Streptococcus pneumoniae, and Mycobacterium tuberculosis.
Proposals should include at least one clinical trial (phase I to IV) in sub-Saharan Africa. Proposals should clearly define the activities and mechanisms to be used within the project, including details of any collaboration with public authorities, international organisations or commercial partnerships that will be established in order to achieve the expected impact.
The total call budget is €18 million. It is expected that 2-4 grants will be awarded.
Deadline: 7 November 2019
Click here for more information.

Strategic Actions Supporting Large-scale Clinical Trials 2019
The purpose of this Call for Proposals is to support strategic actions (clinical research activities) that are part of a large-scale clinical trial with the potential to achieve rapid advances in the clinical development of new or improved medical interventions (drugs, vaccines, microbicides) or diagnostics, including multiplex diagnostic platforms, for PRDs. Proposals for a strategic action must focus on phase III/IV study(ies) or advanced field testing (in the case of diagnostics) on PRDs within the remit of the EDCTP2 programme. The proposed EDCTP2-funded study(ies) should be conducted in sub-Saharan Africa but may form part of a larger trial that is conducted globally.
The total call budget is €20 million. It is expected that 2-4 grants will be awarded.                            Deadline: 7 November 2019
Click here for more information.

H2020 Digital Health Related Calls
This is advance warning for a number of calls which will open 19 November 2019 – they will be highlighted again in the funding tracker once launched.
DT-ICT-12-2020: AI for the smart hospital of the future.
SC1-DTH-02-2020: Personalised early risk prediction, prevention and intervention based on Artificial Intelligence and Big Data technologies.
SC1-DTH-04-2020: International cooperation in smart living environments for ageing people.
DT-TDS-04-2020: AI for Genomics and Personalised Medicine.
DT-TDS-05-2020: AI for Health Imaging.
Deadline: 22 April 2020
Click here for more information

European Research Council: Funding Available
Applicants for the ERC Advanced Grants – called Principal Investigators (PI) – are expected to be active researchers who have a track-record of significant research achievements in the last 10 years.
The Principal Investigators should be exceptional leaders in terms of originality and significance of their research contributions. No specific eligibility criteria with respect to the academic requirements are foreseen.
Applications can be made in any field of research. The ERC’s grants operate on a ‘bottom-up’ basis without predetermined priorities.
Deadline: The new call should open on 14 May 2020
Click here for more information.

Horizon Prize for Early Warning of Epidemics
The objectives of the prize are:
• to develop and demonstrate a scalable, reliable and cost-effective early warning system prototype using Earth Observation data to forecast and monitor vector-borne diseases;
• to contribute to the prevention of outbreaks mitigating their impact on local, regional and global scales and providing support to existing elimination efforts
The prize will be awarded to the entry that best addresses the following cumulative criteria:
– Criterion 1: Operational capability and integration of existing data (Max. 40pts)
– Criterion 2: Demonstrated implementation within an affected community (Max. 40 pts)
– Criterion 3: Scalability and sustainability of the Early Warning Concept (Max. 20 pts)
– Criterion 4: Focus on demonstration of European technology (Max. 20 points)
Deadline: 1 September 2020
Click here for more information

Horizon 2020: SME Instrument – Phase 2
The SME Instrument supports high-risk, high-potential small and medium-sized enterprises to develop and bring to market new products, services and business models that could drive economic growth.
Deadline: 7 October 2020
Click here for more information

Horizon 2020: SME Instrument – Phase 1
The SME Instrument supports high-risk, high-potential small and medium-sized enterprises to develop and bring to market new products, services and business models that could drive economic growth.
Deadline: 4 November 2020
Click here for more information


DIT – Tradeshow Access Programme
The Tradeshow Access Programme provides funding in the form of grants for eligible businesses to attend overseas trade shows. The funding helps your business gain: market knowledge; experience in attending and getting the most from overseas trade shows; advice and support from trade experts.
Deadline: open
Click here for more information